The Maastricht Transplant Center: Clinical setting and epitope searches in HLA class II molecules: Does the structural localization of a polymorphic site contribute to its immunogenicity?

2014 ◽  
Vol 31 (4) ◽  
pp. 213-218 ◽  
Author(s):  
J. Schellekens ◽  
J. Vanderlocht ◽  
M. Groeneweg ◽  
C.E. Voorter ◽  
L. Wieten ◽  
...  
Vox Sanguinis ◽  
1991 ◽  
Vol 61 (2) ◽  
pp. 106-110 ◽  
Author(s):  
Ulrike Westhoff ◽  
Friedrich P. Thinnes ◽  
Hilde Götz ◽  
Hans Grosse-Wilde

2014 ◽  
Vol 34 (5) ◽  
pp. 408-410 ◽  
Author(s):  
Ji Won In ◽  
Eun Youn Rho ◽  
Sue Shin ◽  
Kyoung Un Park ◽  
Eun Young Song

1994 ◽  
Vol 180 (1) ◽  
pp. 165-171 ◽  
Author(s):  
K Yamamoto ◽  
Y Fukui ◽  
Y Esaki ◽  
T Inamitsu ◽  
T Sudo ◽  
...  

Studies in vitro have suggested that a species barrier exists in functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecules. However, whether mouse CD4+ T cells restricted by HLA class II molecules are generated in HLA class II transgenic mice and respond to peptide antigens across this barrier has remained unclear. In an analysis of T cell responses to synthetic peptides in mice transgenic for HLA-DR51 and -DQ6, we found that DR51 and DQ6 transgenic mice acquired significant T cell response to influenza hemagglutinin-derived peptide 307-319 (HA 307) and Streptococcus pyogenes M12 protein-derived peptide 347-397 (M6C2), respectively. Inhibition studies with several monoclonal antibodies showed that transgenic HLA class II molecules presented these peptides to mouse CD4+ T cells. Furthermore, T cell lines specific for HA 307 or M6C2 obtained from the transgenic mice could respond to the peptide in the context of relevant HLA class II molecules expressed on mouse L cell transfectants that lack the expression of mouse MHC class II. These findings indicate that interaction between HLA class II and mouse CD4 molecules is sufficient for provoking peptide-specific HLA class II-restricted T cell responses in HLA class II transgenic mice.


2018 ◽  
Vol 86 (1) ◽  
pp. 85-91 ◽  
Author(s):  
Ayano Yokoi ◽  
Yo Niida ◽  
Mondo Kuroda ◽  
Yoko Imi-Hashida ◽  
Tomoko Toma ◽  
...  

1999 ◽  
Vol 189 (5) ◽  
pp. 767-778 ◽  
Author(s):  
Pascal Chaux ◽  
Valérie Vantomme ◽  
Vincent Stroobant ◽  
Kris Thielemans ◽  
Jurgen Corthals ◽  
...  

MAGE-type genes are expressed by many tumors of different histological types and not by normal cells, except for male germline cells, which do not express major histocompatibility complex (MHC) molecules. Therefore, the antigens encoded by MAGE-type genes are strictly tumor specific and common to many tumors. We describe here the identification of the first MAGE-encoded epitopes presented by histocompatibility leukocyte antigen (HLA) class II molecules to CD4+ T lymphocytes. Monocyte-derived dendritic cells were loaded with a MAGE-3 recombinant protein and used to stimulate autologous CD4+ T cells. We isolated CD4+ T cell clones that recognized two different MAGE-3 epitopes, MAGE-3114–127 and MAGE-3121–134, both presented by the HLA-DR13 molecule, which is expressed in 20% of Caucasians. The second epitope is also encoded by MAGE-1, -2, and -6. Our procedure should be applicable to other proteins for the identification of new tumor-specific antigens presented by HLA class II molecules. The knowledge of such antigens will be useful for evaluation of the immune response of cancer patients immunized with proteins or with recombinant viruses carrying entire genes coding for tumor antigens. The use of antigenic peptides presented by class II in addition to peptides presented by class I may also improve the efficacy of therapeutic antitumor vaccination.


Blood ◽  
1996 ◽  
Vol 87 (9) ◽  
pp. 3970-3976 ◽  
Author(s):  
F Garban ◽  
M Ericson ◽  
C Roucard ◽  
C Rabian-Herzog ◽  
H Teisserenc ◽  
...  

Fetal mononuclear cells are increasingly used in transplantation of hematopoietic cells due to a reportedly lower incidence of graft-versus- host disease. Previous studies of immune responses of fetal lymphocytes have indicated a general hyporesponsiveness in response to polyclonal stimulation. Fetal B lymphocytes display many features typical of the resting state such as a low level of HLA class II expression, but a large proportion of cells also carry the activation-associated CD23 antigen. We show here that despite a low cell surface level of all three HLA class II isotypes on fetal B cells, their allogeneic capacity, measured as the ability to elicit a mixed lymphocyte reaction, is similar to that of adult B cells. Allogeneic stimulation is believed to be peptide-dependent. Surprisingly, the majority of the HLA class II molecules on cord blood B cells appeared to be devoid of stably bound peptide as detected by the binding of a recombinant and soluble invariant chain, as well as by the absence of sodium dodecyl sulfate (SDS) stable alpha beta heterodimers in whole cell lysates. Immunoblot experiments showed that HLA class II molecules of fetal B cells were predominantly present in high molecular weight aggregates in stark contrast to B cells of adult origin. However, a sensitive cell surface labeling technique followed by immunoprecipitation enabled us to detect an SDS-stable 120-kD molecule on fetal B cells. We propose that the 120-kD molecules could correspond to HLA class II doubledimers or superdimers. We hypothesize that the 120-kD HLA class II molecule functions as the antigen-presenting molecule in the mixed lymphocyte reaction of fetal B cells, as it is the major species detected on the surface. Secondly, we suggest that a high level of empty HLA class II molecules may be indicative of a particular stage in B-cell ontogeny.


2003 ◽  
Vol 38 ◽  
pp. 215-216
Author(s):  
R.J. Andrade ◽  
M.I. Lucena ◽  
R. Benitez ◽  
A. Alonso ◽  
M. Garcia-Cortes ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document